Literature DB >> 22893035

Inflammatory cells of immunosuppressive phenotypes in oral lichen planus have a proinflammatory pattern of expression and are associated with clinical parameters.

Marilena Vered1, Eran Fürth, Yifat Shalev, Dan Dayan.   

Abstract

OBJECTIVES: We sought to investigate the expression of cells with immunosuppressive/protumorigenic phenotypes in oral lichen planus (OLP), such as M2-tumor-associated macrophages (TAM2), myeloid-derived suppressive cells (MDSCs), and regulatory T cells (Tregs) in association with clinical parameters.
MATERIALS AND METHODS: Cases of hyperkeratotic (HK)-OLP (n = 23) and erosive (E)-OLP (n = 26) were immunohistochemically stained to determine the percentages of CD163-TAM2, CD80-MDSCs, and FOXP3-Tregs of proinflammatory CD121a-Th17, CD4 and CD8 lymphocytes, and of cells positive for nuclear factor kappa B (NF-κB) and transforming growth factor beta. Clinical parameters included symptoms, treatment approach, treatment response, and others.
RESULTS: The inflammatory infiltrate in HK-OLP and E-OLP contained immunosuppressive cells; however, their pattern of expression was compatible with a proinflammatory response [membranous CD163-TAM2 staining (not extracellular), CD80+ lymphocytes (not macrophages), and a few Tregs]. The presence of CD4+, CD8+, and CD121a+ T lymphocytes was extensive. TAM2 were more frequent in E-OLP than in HK-OLP (P = 0.017). A higher frequency of CD80+ lymphocytes was associated with partial to no response to treatment (P = 0.028). Nuclear expression of NF-κB in the inflammatory cells was absent.
CONCLUSIONS: The pattern of expression of the immunosuppressive cells, together with numerous CD4+, CD8+, and Th17-CD121a+ lymphocytes, suggest an extensive proinflammatory response rather than an immunosuppressive/protumorigenic response. CLINICAL RELEVANCE: The frequency of selective types of inflammatory cells calls for individual profile analyses of inflammatory infiltrates and individually adjusted treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22893035     DOI: 10.1007/s00784-012-0814-1

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  41 in total

1.  Immunohistopathological study of the oral lichenoid lesions of chronic GVHD.

Authors:  M Sato; N Tokuda; T Fukumoto; T Mano; T Sato; Y Ueyama
Journal:  J Oral Pathol Med       Date:  2006-01       Impact factor: 4.253

Review 2.  Chemokines in cancer related inflammation.

Authors:  Paola Allavena; Giovanni Germano; Federica Marchesi; Alberto Mantovani
Journal:  Exp Cell Res       Date:  2010-12-04       Impact factor: 3.905

3.  High-dose curcuminoids are efficacious in the reduction in symptoms and signs of oral lichen planus.

Authors:  Nita Chainani-Wu; Erin Madden; Francina Lozada-Nur; Sol Silverman
Journal:  J Am Acad Dermatol       Date:  2011-09-09       Impact factor: 11.527

Review 4.  Biologics, an alternative therapeutic approach for oral lichen planus.

Authors:  Jing Zhang; Gang Zhou; Ge-Fei Du; Xue-Yi Xu; Hong-Mei Zhou
Journal:  J Oral Pathol Med       Date:  2011-04-05       Impact factor: 4.253

Review 5.  Regulatory T cells and cancer.

Authors:  Helen Y Wang; Rong-Fu Wang
Journal:  Curr Opin Immunol       Date:  2007-02-15       Impact factor: 7.486

6.  A subpopulation of CD163-positive macrophages is classically activated in psoriasis.

Authors:  Judilyn Fuentes-Duculan; Mayte Suárez-Fariñas; Lisa C Zaba; Kristine E Nograles; Katherine C Pierson; Hiroshi Mitsui; Cara A Pensabene; Julia Kzhyshkowska; James G Krueger; Michelle A Lowes
Journal:  J Invest Dermatol       Date:  2010-06-17       Impact factor: 8.551

7.  Blockade of B7-H1 on macrophages suppresses CD4+ T cell proliferation by augmenting IFN-gamma-induced nitric oxide production.

Authors:  Tomohide Yamazaki; Hisaya Akiba; Akemi Koyanagi; Miyuki Azuma; Hideo Yagita; Ko Okumura
Journal:  J Immunol       Date:  2005-08-01       Impact factor: 5.422

8.  Interleukin 1 participates in the development of anti-Listeria responses in normal and SCID mice.

Authors:  H W Rogers; K C Sheehan; L M Brunt; S K Dower; E R Unanue; R D Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-01       Impact factor: 11.205

9.  Neutrophil chemotaxis and local expression of interleukin-10 in the tolerance of endotoxin-induced uveitis.

Authors:  Hisashi Mashimo; Nobuyuki Ohguro; Shintaro Nomura; Noriyasu Hashida; Kei Nakai; Yasuo Tano
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-08-29       Impact factor: 4.799

Review 10.  The pathogenesis of oral lichen planus.

Authors:  P B Sugerman; N W Savage; L J Walsh; Z Z Zhao; X J Zhou; A Khan; G J Seymour; M Bigby
Journal:  Crit Rev Oral Biol Med       Date:  2002
View more
  8 in total

1.  Interaction between oral lichen planus and chronic periodontitis with Th17-associated cytokines in serum.

Authors:  Hui Wang; Zhenhua Luo; Lei Lei; Zheng Sun; Min Zhou; Hongxia Dan; Xin Zeng; Qianming Chen
Journal:  Inflammation       Date:  2013-06       Impact factor: 4.092

2.  Chronic atrophic gastritis aggravate chronic periodontitis with Helicobacter pylori infection and CD4+Th cytokines infiltration.

Authors:  Wei Luo; Yaqiang Li; Zhenhua Luo; Baohong Xu
Journal:  Histol Histopathol       Date:  2019-11-21       Impact factor: 2.303

Review 3.  Does oral lichen planus aggravate the state of periodontal disease? A systematic review and meta-analysis.

Authors:  Gabriel Pereira Nunes; Beatriz Ommati Pirovani; Larissa Pereira Nunes; Arles Naisa Amaral Silva; Maria Juliana Sismeiro Dias Morábito; Nilson Antônio Nunes-Júnior; Alberto Carlos Botazzo Delbem; Túlio Morandin Ferrisse
Journal:  Clin Oral Investig       Date:  2022-02-08       Impact factor: 3.573

Review 4.  Artemisinin and its derivatives: a potential therapeutic approach for oral lichen planus.

Authors:  Rui-Jie Ma; Ming-Jing He; Ya-Qin Tan; Gang Zhou
Journal:  Inflamm Res       Date:  2019-02-01       Impact factor: 4.575

5.  Oral lichen planus may enhance the expression of Th17-associated cytokines in local lesions of chronic periodontitis.

Authors:  Hui Wang; Qi Han; Zhenhua Luo; Caixia Xu; Jiajia Liu; Hongxia Dan; Yi Xu; Xin Zeng; Qianming Chen
Journal:  Clin Oral Investig       Date:  2013-12-05       Impact factor: 3.573

Review 6.  Myeloid derived suppressor cells in physiological and pathological conditions: the good, the bad, and the ugly.

Authors:  Paolo Serafini
Journal:  Immunol Res       Date:  2013-12       Impact factor: 4.505

Review 7.  Cutaneous and mucosal lichen planus: a comprehensive review of clinical subtypes, risk factors, diagnosis, and prognosis.

Authors:  Farzam Gorouhi; Parastoo Davari; Nasim Fazel
Journal:  ScientificWorldJournal       Date:  2014-01-30

8.  Oral lichen-planus-associated fibroblasts acquire myofibroblast characteristics and secrete pro-inflammatory cytokines in response to Porphyromonas gingivalis lipopolysaccharide stimulation.

Authors:  Liping Wang; Yinshen Yang; Xiaoqin Xiong; Ting Yu; Xinhong Wang; Wenxia Meng; Haiyan Wang; Gang Luo; Linhu Ge
Journal:  BMC Oral Health       Date:  2018-11-29       Impact factor: 2.757

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.